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Aim: There is a paucity of information about changes in splenic volume after surgery. The aim of this 
study was to investigate postoperative changes in splenic volume（SV）and the factors influencing SV 
after spleen-preserving distal pancreatectomy（SPDP）with conservation of the splenic artery and vein 
（CSAV）, and after surgery of the digestive tract and breast. 
Methods: We investigated 113 patients who underwent SPDP with CSAV（n=7）, breast surgery
（n=24）, colorectal surgery（n=45）, distal gastrectomy（n=27）and total gastrectomy（n=10）. SV changes 
were determined for three years after surgery using volumetry based on computed tomographic 
imaging, and splenic vein diameter changes after SPDP with CSAV were also determined.
Results: Splenic vein diameter after SPDP with CSAV did not change during 3 years. SV did not 
change significantly during 3 years after SPDP with CSAV and distal gastrectomy. After breast and 
colorectal surgery, and total gastrectomy, SV was decreased. 
Conclusions: Postoperative SV changes differed according to the type of surgery. SV did not change 
significantly during 3 years after SPDP with CSAV. 
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Introduction
The spleen is the largest peripheral lymphoid 
organ and plays an important role in immune 
function１）．Overwhelming post -splenectomy 
infection （OPSI） occurs in 3.2% of all splenectomized 
patients２）．A method of spleen-preserving distal 
pancreatectomy （SPDP） with conservation of the 
splenic artery and vein （CSAV） that emphasized 
the importance of splenic vein dissection from the 
pancreatic body to the tail was first reported by 
Kimura et al３）．Another way of preserving blood 
flow to the spleen in SPDP is preservation of the 
short gastric and left gastroepiploic vessels with 
excision of the splenic vessels，which is called 
Warshaw’s procedure４）．Warshaw’s procedure is 
technically easier but recently the importance of 
preserving the splenic vessels in SPDP has been 
widely recognized５）.
Recently，it has been reported that a small spleen 
（<1.1 cm３/kg） in patients who do not undergo 
splenectomy is a risk factor for severe infection６）． 
Therefore，preservation of splenic function is very 
important in pancreatic surgery．No standard 
method for assessment of splenic function has yet 
been established，although some authors have 
proposed that the appearance of Howell-Jolly bodies 
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in peripheral blood，or measurement of splenic 
volume （SV），could be useful in this respect７）．
To date，few reports have documented changes 
in SV after pancreatic surgery，including SPDP with 
CSAV，and other forms of surgery.
The aim of the present study was to determine 
the changes in SV after SPDP with CSAV，and 
after digestive tract and breast surgery，using an 
image-processing workstation based on computed 
tomography （CT） imaging data，and to reveal the 
possible factors that influence postoperative changes 
in SV．
Materials and Methods
The present study was based on 129 patients who 
underwent surgery at Yamagata University Hospital 
between June 2006 and May 2008．Seven patients 
underwent SPDP with CSAV，29 underwent breast 
surgery，54 underwent colorectal surgery，29 
underwent distal gastrectomy and 10 underwent 
total gastrectomy．Patients who had conditions 
possibly influencing SV，such as liver cirrhosis 
（n=3），infections at the time of CT scan （n=2），
postoperative hematological disorder （n=1），
portal vein tumor thrombosis due to postoperative 
recurrence （n=1），and postoperative oxaliplatin 
chemotherapy （n=2） within 3 years after surgery 
were excluded．Patients who underwent surgery 
involving other intra-abdominal organs concomitantly 
or within 3 years after surgery were also excluded 
（n=7）．Accordingly，we investigated a final total 
of 113 patients who underwent SPDP with CSAV 
（n=7），breast surgery （n=24），colorectal surgery 
（n=45），distal gastrectomy （n=27） and total 
gastrectomy （n=10）．
We verified the preoperative and follow-up 
（1，2 and 3 years after surgery） postcontrast 
CT images of all patients．Data pertaining to pre- 
and postoperative clinical characteristics [age at 
surgery，sex，preoperative body weight，BMI，
SV and SV/BMI ratio，pre- and postoperative 
laboratory data such as white blood cell count，
platelet count，red blood cell count，albumin，and 
C-reactive protein （CRP） level，surgical procedure，
pathology，stage，adjuvant chemotherapy and 
hormonal therapy，and postoperative body weight 
change] were collected retrospectively from the 
hospital charts．The staging of each cancer was 
defined in accordance with the 7th edition of the 
American Joint Committee on Cancer （AJCC） 
staging criteria８）．
SPDP with CSAV was performed for low-grade 
malignant lesions in the body or tail of the pancreas 
without obvious stromal invasion or lymph node 
metastasis，as judged based on imaging modalities 
and operative findings．For the other operations，
the surgical procedures were selected based 
on tumor location，size，depth of invasion and 
lymph node metastasis，and regional lymph node 
dissections were performed for malignancy．
In the colorectal surgery，distal gastrectomy and 
total gastrectomy groups，patients with lymph node 
metastasis received adjuvant chemotherapy with oral 
fluoropyrimidine drugs for 1–2 years，depending on 
the situation．
Breast surgery patients received adjuvant 
chemotherapy for about 6 months after surgery 
depending on the situation．Female patients with 
estrogen receptor positive cancer received hormonal 
therapy with tamoxifen for 5 years and/or LH-
RH agonist for 2 years if premenopausal，or with 
a
Figure 1.
b
c
P.21Fig 1．Splenic volume measurements
The spleen was outlined by manual contouring on a Zio 
workstation （a, b）. 3-Dimensional computed tomography 
images of the spleen were constructed by volume 
rendering （c）, and the value of SV was calculated 
automatically.
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aromatase inhibitor for 5 years if postmenopausal．
After adjuvant chemotherapy，patients with 
estrogen receptor-positive cancer sequentially 
rece ived hormonal  therapy．Postoperat ive 
radiotherapy （approximately 50 Gy to the whole 
breast and an additional 10 Gy for some patients） 
was performed for the remnant breast after breast-
conserving surgery．
The study was approved by the hospital ethics 
committee．
Summary of surgical procedures
SPDP with CSAV was performed using Kimura’s 
procedure３）．An important aspect of this method 
is dissection of the splenic vein from the pancreatic 
body to the tail after mobilization of the spleen and 
distal pancreas from the retroperitoneum３）．The 
left gastroepiploic and short gastric vessels were 
dissected in this cohort．Hand-assisted laparoscopic-
SPDP with CSAV was performed using the method 
reported previously９），10）．For distal gastrectomy，
the left gastroepiploic vessels were dissected．
Splenic volume and splenic vein measurements
All CT imaging examinations were performed 
using multi-detector CT （MDCT） scanners （an 
Aquilion 64 [Toshiba Medical Systems，Tokyo，
Japan] or a SOMATOM Sensation 32 [Siemens 
Medical Solutions，Forchheim，Germany]） with a 
1-mm slice thickness in the equilibrium phase （120 
seconds after initiation of IV contrast injection）．SV 
values were calculated automatically on a Ziostation 
version 1．17 （Ziosoft Inc．，Tokyo，Japan） using 
manual contouring of the spleen．
Splenic vein diameters were measured on axial 
images on the workstation at the following four 
points （Fig．2）: junction of the splenic vein and 
portal vein （SVｊ）; 2 cm distal to the SVｊ （SVｊ－２）; 
junction of the splenic vein branches at the splenic 
hilum （SVｔ）; 2 cm proximal to the SVｔ （SVｔ－２）．
Statistical analysis
Numerical data are expressed as mean ± 
standard deviation．Statistical analysis for paired 
data was done using the Wilcoxon signed rank test．
Categorical variables were analyzed using Fisher’s 
exact test．Continuous variables were analyzed 
by Kruskal-Wallis test．Statistical analysis was 
performed using SAS version 9．4 （SAS Institute 
Inc．，Cary，NC）．Differences at p<0．05 were 
considered statistically significant．
Results
Pre-and postoperative clinical characteristics of each 
surgical procedure 
Table 1 summarizes the clinicopathological 
characteristics of the patients．The mean age of the 
patients overall at the time of surgery was 66．0 ± 
11．8 years （range: 35-87）．The preoperative mean 
SV for the patients overall was 117 ± 58 cm３ （range: 
27-378 cm３）．
Among the 113 patients，107 （94．7%） had 
malignant disease．The pathological diagnoses in the 
patients who underwent SPDP with CSAV included 
intraductal papillary mucinous neoplasm （IPMN） 
with low- or intermediate-grade dysplasia （n=5），
IPMN with an associated invasive carcinoma （n=1） 
and pancreatic neuroendocrine neoplasm （n=1）．
One patient who underwent SPDP with CSAV 
received adjuvant chemotherapy with gemcitabine．
Patients in the colorectal surgery group received 
oral fluoropyrimidine （n=17），and those in the distal 
gastrectomy （n=4） and total gastrectomy （n=2） 
groups received oral fluoropyrimidine．Patients 
in the breast surgery group received adjuvant 
hormonal therapy with LH-RH agonist （n=1），LH-
RH agonist and tamoxifen （n=2），tamoxifen （n=6），
and aromatase inhibitor （n=7）．Recurrence within 
SVj
SVj-2
2 cm
SVt-2
SVt
2 cm
＊
Figure ２.
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Fig 2．Splenic vein diameter measurements
Splenic vein diameters were measured on axial images on 
the workstation at the following four points: junction of 
the splenic vein and portal vein （SVｊ）; 2 cm distal to the 
SVｊ （SVｊ－２）; junction of the splenic vein branches at the 
splenic hilum （SVｔ）; 2 cm proximal to the SVｔ （SVｔ－２）． 
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3 years was observed in 1 of the 10 patients in the 
total gastrectomy group．
Postoperative changes in splenic vein diameter of 
SPDP with CSAV
Postoperative changes in splenic vein diameter 
after SPDP with CSAV are shown in Table 2．
Splenic vein diameter after SPDP with CSAV 
was not change significantly during 3 years after 
surgery．
Postoperative changes in splenic volume
Postoperative changes in SV after each type 
of surgery are shown in Table 3 and Figure 3．
SV after SPDP with CSAV and distal gastrectomy 
did not change significantly until 3 years after 
surgery．SV after breast surgery was decreased 
significantly from 1 year after surgery in comparison 
with the preoperative SV （128±65 vs． 116±56 
cm３，p<0．001）．SV after total gastrectomy was 
decreased significantly from 2 years after surgery in 
comparison with the preoperative SV （122±63 vs．
102±38 cm３，p=0．020）．In both the breast surgery 
and total gastrectomy groups，SV reached a plateau 
from 2 years after surgery．In the colorectal surgery 
group，SV was decreased significantly at 2 years 
after surgery in comparison with the preoperative 
SV （117±61 vs．111±58 cm３，p=0．006）．In the 
patients overall，SV was decreased significantly 
from 1 year after surgery （117±58 vs．113±52 cm３， 
p=0．006），and reached a plateau from 2 years after 
surgery．
Table 1. Clinicopathological characteristics of patients
Variable Total 
(n=113) 
SPDP with 
CSAV  
(n=7)
Colorectal 
surgery  
(n=45)
Distal 
gastrectomy 
(n=27) 
Total 
gastrectomy 
(n=10)
Breast surgery
(n=24) 
P value
Age at surgery 66.0 ± 11.8 67.1 ± 10.8 69.3 ± 9.6 68.1 ± 9.0 67.4 ± 15.0 57.3 ± 13.8 0.017
Sex, male/ female 65 (57.5 %)/
48 (42.5 %)
7 (100 %)/
0
29 (64.4 %)/
16 (35.6 %)
21 (77.8 %)/
6(22.2 %) 
8 (80 %)/
2 (20 %)
0/
24 (100 %)
<0.001
Preoperative body weight (kg) 58.9 ± 10.6 58.3 ± 6.7 59.2 ± 11.2 58.9 ± 10.6 63.4 ± 13.4 56.5 ± 9.3 0.545
Preoperative BMI (kg/m2) 23.2 ± 3.4 21.7 ± 2.2 23.2 ± 3.4 22.9 ± 3.4 23.9 ± 3.7 23.8 ± 3.7 0.522
Preoperative SV (cm3) 117 ± 58 131 ± 59 117 ± 61 103 ± 43 122 ± 63 128 ± 65 0.655
Preoperative SV/BMI ratio 5.0 ± 2.2 6.0 ± 2.4 5.0 ± 2.3 4.5 ± 1.7 5.2 ± 2.9 5.4 ± 2.4 0.514
Preoperative laboratory data 
White blood cell count (/μl) 
Red blood cell count (×104/μl) 
Platelet count (×104/μl) 
Albumin (g/dl) 
CRP (mg/dl)
5702 ± 1525
424±54 
25.4 ± 7.3 
4.1 ± 0.5 
0.4 ± 0.8
4634 ± 902 
424±49 
19.6 ± 4.8 
4.1 ± 0.2 
0.3 ± 0.5
5764 ± 1275 
424±56 
27.1 ± 7.9 
3.9 ± 0.4 
0.5 ± 1.0
 
5727 ± 1650 
428±48 
25.2 ± 6.4 
4.1 ± 0.5 
0.4 ± 0.9 
5476 ± 1338 
438±62 
23.5 ± 7.5 
4.3 ± 0.6 
0.3 ± 0.4
5964 ± 1943 
417±56 
25.2 ± 6.9 
4.2 ± 0.6 
0.3 ± 0.5
0.280 
0.913 
0.079 
0.207 
0.442
Pathology and Stage
 Benign or stage 0/Ⅰ 
 Stage Ⅱ/Ⅲ
60 (53.1 %)
53 (46.9 %)
7 (100 %) 
0
15 (33.3 %) 
30 (66.7 %)
 
21 (77.8 %) 
6 (22.2 %) 
6 (60 %) 
4 (40 %)
11 (45.9 %) 
13 (54.1 %)
<0.001
Adjuvant chemotherapy 35 (30.9%) 1 (14.3 %) 17 (37.8 %) 4 (14.8 %) 2 (20 %) 11 (45.9 %) 0.085
Adjuvant hormonal therapy 16 (14.2 %) 0 0 0 0 16 (66.7 %) <0.001
Radiation therapy 9 (8 %) 0 0 0 0 9 (37.5 %) <0.001
Values are mean ± standard deviation or n (%)
SV splenic volume, SPDP spleen-preserving distal pancreatectomy, CSAV conservation of the splenic artery and vein 
a(Preoperative value - mean BW from 1 to 3 years after surgery)/preoperative value×100 (%)
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Table 1．Clinicopathological characteristics of patients
Table 2． Splenic vein diameter changes after spleen-preserving distal pancreatectomy with
 conservation of the splenic artery and vein
 
Table 2. Splenic vein diame er changes after s lee -prese ving distal pancreatectomy with conservation of the splenic artery and vein 
 Preoperative 
value 
1 year after 
surgery 
p value* 2 years after 
surgery 
p value* 3 years after 
surgery 
p value* 
SVj (mm) 6.9 ± 1.7 7.8 ± 1.8 0.578 7.6 ± 1.6 0.469 7.8 ± 1.6 0.469 
SVj-2 (mm)  8.2 ± 2.0 8.5 ± 3.0 0.563 8.8 ± 2.6 0.375 8.4 ± 2.1 0.344 
SVt-2 (mm) 7.0 ± 1.7 7.3 ± 1.9 0.469 7.5 ± 1.4 0.219 7.3 ± 1.5 0.219 
SVt (mm) 7.0 ± 1.0 7.4 ± 1.1 0.563 7.6 ± 0.8 0.156 7.4 ± 0.8 0.203 
Values are mean ± standard deviation 
*Comparison between the preoperative splenic vein diameter and splenic vein diameter obtained after surgery by the use of Wilcoxon
signed-rank test 
 
P.19
－88－
Postoperative changes in splenic volume
Discussion
Studies from Japanese institutions have reported 
the mean SV ranging from 112–127 cm３ 11），12）．The 
preoperative mean SV in the present study population 
was 116 cm３，and thus within the reported range．
The mean SV in studies from western countries is 
larger，ranging from 209–219 cm３ 13）－15）．Several 
recent reports have documented changes in splenic 
volume （SV） in various conditions11），16）－18）．SV is 
affected by various factors; for example，in adults 
it is correlated with height13），weight13），12），body 
mass index （BMI） and body surface area12），and 
inversely related to age12），19）．It is reported that SV 
is increased in the presence of higher portal venous 
pressure20），infection21），inflammatory，hematologic 
and metabolic disorders22），cytotoxic chemotherapy 
including oxaliplatin16） and certain drugs23），whereas 
it is reduced by drugs23），decreased arterial flow to 
the spleen24），and radiation therapy18）．
In this study，SV did not change significantly 
after SPDP with CSAV．This may be because both 
blood flow from the splenic artery and venous return 
through the splenic vein may have been sufficiently 
preserved．Splenic volume reduction may be a risk 
factor for severe infection．Therefore，Kimura’s 
procedure is excellent in terms of preservation of 
splenic function．It is reported that 32．4% （12/37） 
of patients who underwent Warshaw’s procedure，
which does not preserve the splenic vessels，had 
splenic enlargement of more than 20% compared to 
the preoperative value，at a follow-up CT 6 months 
after surgery25）．In the present study，splenic 
enlargement exceeding 20% was not observed 
after SPDP with CSAV．However，in patients 
undergoing laparoscopic distal pancreatectomy，
splenic enlargement of more than 20% compared to 
the preoperative SV was observed in 59% （10/17） of 
patients treated using Warshaw’s method and 43% 
（3/7） of patients in whom the splenic vessels were 
preserved17）．Splenic venous occlusion after SPDP 
with CSAV has been described in some reports26），
but in the present study no obvious splenic vein 
occlusion or stenosis was observed．Splenic vein 
patency may influence the postoperative SV．Careful 
 
Table 3. Splenic volume change after surgery 
 preoperative 1 year after 
surgery 
2 years after 
surgery 
3 years after 
surgery 
SPDP with CSAV (cm3) (n=7)  
(%)a 
131 ± 59 
(100 %) 
135 ± 55 
(104 ± 4 %) 
133 ± 54 
(102 ± 6 %) 
131 ± 49 
(101 ± 6 %) 
Colorectal surgery (cm3) (n=45)  
(%)a  
117 ± 61 
(100 %) 
114 ± 58 
(98 ± 11 %) 
111 ± 58* 
(95 ± 13 %) 
112 ± 56 
(98 ± 17 %) 
Distal gastrectomy (cm3) (n=27)  
(%)a 
103 ± 42 
(100 %) 
105 ± 42 
(103 ± 17 %) 
101 ± 38 
(100 ± 20 %) 
100 ± 36 
(99 ± 19 %) 
Total gastrectomy (cm3) (n=10) 
(%)a 
122 ± 63 
(100 %) 
108 ± 44 
(93 ± 13 %) 
102 ± 38* 
(89 ± 14 %) 
103 ± 42* 
(89 ± 17 %) 
Breast surgery (cm3) (n=24) 
(%)a 
128 ± 65 
(100 %) 
116 ± 56* 
(92 ± 13 %) 
112 ± 56* 
(90 ± 15 %) 
112 ± 57* 
(90 ± 15 %) 
Total (cm3) (n=113) 
(%)a 
117 ± 58 
(100 %) 
113 ± 52* 
(98 ± 13 %) 
109 ± 51* 
(94.0 ± 15 %) 
110 ± 51* 
(95.9 ± 17 %) 
Values are mean ± standard deviation 
SPDP spleen-preserving distal pancreatectomy, CSAV conservation of the splenic artery and vein,  
a(splenic volume at each point/preoperative splenic volume)×100 (%) 
*P<0.05; Comparison between the preoperative splenic volume and splenic volume obtained after surgery by the use of 
Wilcoxon signed-rank test 
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conservation of the splenic artery and vein.
－89－
Tezuka, Kimura, Hirai, Watanabe, Sugawara, Fukumoto, Okazaki, Yano, Hachiya, Suzuki
ligation and cutting of the splenic vein branches are 
required to avoid injury to the venous wall．
In relation to post-gastrectomy changes in SV，
Oida et al．27） in an ultrasonographic study reported 
that the diameter of the spleen in terms of maximum 
bipolar diameter increased after DG and TG．In 
our present study，however，SV after DG did not 
change significantly until 3 years after surgery，
and SV after TG were significantly decreased 
from 2 years after surgery in comparison with 
the preoperative value． Postoperative splenic 
enlargement of more than 20% relative to the 
preoperative volume was seen in 11% （3/27） of 
patients after DG，and in 10% （1/10） of patients 
after TG at any postoperative point．These results 
suggest that splenic enlargement after gastrectomy 
may not be a common phenomenon．In this 
study，SV after distal gastrectomy did not change 
significantly during 3 years after surgery，but SV 
after total gastrectomy was significantly decreased 
starting at 2 years after surgery compared with the 
preoperative value．Post-gastrectomy body weight 
loss is a common phenomenon28）．Body weight 
change is one of the factors that influence SV12），13）． 
Therefore，the body weight loss may partially 
contribute to SV reduction after surgery in total 
gastrectomy．In distal gastrectomy，most of the 
venous outflow from the remnant stomach enters the 
splenic vein through the short gastric vein，and this 
increased flow in the splenic vein may cause relative 
congestion，which may prevent postoperative SV 
reduction．
In patients who underwent colorectal and breast 
surgery，which may not influence hemodynamics 
around the spleen，the mean SV after surgery 
was significantly decreased compared with the 
preoperative value．Aging is a factor that influences 
SV because the spleen becomes smaller with age12），19）． 
However，because there were no obvious decreases 
in SV between 2 and 3 years after surgery，the 
effects of aging on SV changes may have been 
limited．In patients with malignant tumors，the 
spleen is reported to be immunologically reactive 
against the tumor29），thus leading to an increase in 
SV29）－31）．
In this series，adjuvant hormonal therapy with 
tamoxifen and/or LH-RH agonist，or aromatase 
inhibitor，was performed for estrogen receptor-
positive breast cancer．Tamoxifen is a selective 
estrogen receptor modulator．On the relationship 
between estrogen and SV，an animal study has 
demonstrated that estrogen caused an increase in 
the weight of the spleen32）．In humans，estrogen 
receptor is present in many organs，including the 
spleen33），and modulation of estrogen receptor 
by tamoxifen or a decrease in the level of serum 
estrogen by treatment with LH-RH agonist or 
aromatase inhibitor may cause SV reduction．
In conclusion，SV did not change significantly 
after SPDP with CSAV．SPDP with CSAV may 
be a feasible method for appropriate cases．In this 
study，the pattern of postoperative change in the 
SV differs for each type of surgery and most patients 
showed a decrease in SV after surgery．Determining 
the specific mechanism of these changes in SV and 
its significance require further investigation．
Conflicts of interest　Koji Tezuka and co-authors 
have no conflicts of interest．
Abbreviations: AJCC; American Joint Committee 
on Cancer，BMI; body mass index，CRP; C-reactive 
protein，CSAV; conservation of the splenic artery 
and vein，CT; computed tomography，IPMN; 
intraductal papillary mucinous neoplasm，OPSI; 
overwhelming post-splenectomy infection，SPDP; 
spleen-preserving distal pancreatectomy，SV; splenic 
volume．
References
１． Morris OD: The immune function of the spleen. In: 
Bowdler AJ, ed. The Complete Spleen: Structure, 
Function, and Clinical Disorders. 2nd ed. Totowa; 
Humana Press, 2002: 51-69
２． Bisharat N, Omari H, Lavi I, Raz R: Risk of infection 
and death among post-splenectomy patients. J Infect 
2001; 43: 182-186
３． Kimura W, Inoue T, Futakawa N, Shinkai H, Han I, 
Muto T: Spleen-preserving distal pancreatectomy 
with conservation of the splenic artery and vein. 
Surgery 1996; 120: 885-890
－90－
Postoperative changes in splenic volume
４． Warshaw AL: Conservation of the spleen with distal 
pancreatectomy. Arch Surg 1988; 123: 550-553 
５． Beane JD, Pitt HA, Nakeeb A, Schmidt CM, House 
MG, Zyromski NJ, et al. : Splenic preserving distal 
pancreatectomy: does vessel preservation matter? J 
Am Coll Surg 2011; 212: 651-657
６． Koga Y, Fujita M, Nakahara T, Yagi T, Miyauchi T, 
Kaneda K, et al. : Splenic volume in severe sepsis is 
associated with disease severity and pneumococcal 
infection. Acute Med Surg 2016; 3; 3: 339-344
７． Higashi T, Kimura S, Matsumoto S, Muto N, Yamanoi 
T, Nakamura K, et al. : Relationship between the 
appearance of Howell-Jolly bodies and spleen volume 
calculated by CT. J Jpn Soc Intensive Care Med 
2013; 20: 395-399
８． Edge SB, Byrd DR, Compton CC, Fritz AG, Greene 
FL, Trotti A, eds. AJCC cancer staging manual, 7th 
ed. New York; Springer, 2010
９． Kimura W, Yano M, Sugawara S, Okazaki S, 
Sato T, Moriya T, et al. : Spleen-preserving distal 
pancreatectomy with conservation of the splenic 
artery and vein: techniques and its significance. J 
Hepatobiliary Pancreat Sci 2010; 17: 813-823
10． Tezuka K, Kimura W, Hirai I, Moriya T, Watanabe 
T, Yano M: Postoperative hematological changes 
after spleen-preserving distal pancreatectomy with 
preservation of the splenic artery and vein. Dig Surg 
2012; 29: 157-164
11． Kaneko J, Sugawara Y, Akamatsu N, Kokudo N, 
Makuuchi M: Spleen volume and platelet number 
changes after living donor liver transplantation in 
adults. Hepatogastroenterology 2004; 51: 262-263
12． Harris A, Kamishima T, Hao HY, Kato F, Omatsu 
T, Onodera Y, et al. : Splenic volume measurements 
on computed tomography utilizing automatically 
contouring software and its relationship with age, 
gender, and anthropometric parameters. Eur J Radiol 
2010; 75: e97-101
13． Geraghty EM, Boone JM, McGahan JP, Jain K: 
Normal organ volume assessment from abdominal 
CT. Abdom Imaging 2004; 29: 482-490
14． Henderson JM, Heymsfield SB, Horowitz J, Kutner 
MH: Measurement of liver and spleen volume by 
computed tomography. Assessment of reproducibility 
and changes found following a selective distal 
splenorenal shunt. Radiology 1981; 141: 525-527
15． Prassopoulos P, Daskalogiannaki M, Raissaki M, 
Hatjidakis A, Gourtsoyiannis N: Determination of 
normal splenic volume on computed tomography in 
relation to age, gender and body habitus. Eur Radiol 
1997; 7: 246-248
16． Angitapalli R, Litwin AM, Kumar PR, Nasser E, 
Lombardo J, Mashtare T, et al. : Adjuvant FOLFOX 
chemotherapy and splenomegaly in patients with 
stages II-III colorectal cancer. Oncology 2009; 76: 363-
368
17． Matsushima H, Kuroki T, Adachi T, Kitasato A, 
Hirabaru M, Hidaka M, et al. : Laparoscopic spleen-
preserving distal pancreatectomy with and without 
splenic vessel preservation: the role of the Warshaw 
procedure. Pancreatology. 2014; 14: 530-535
18． Trip AK, Sikorska K, van Sandick JW, Heeg M, Cats 
A, Boot H, et al. : Radiation-induced dose-dependent 
changes of the spleen following postoperative 
chemoradiotherapy for gastric cancer. Radiother 
Oncol 2015; 116: 239-244
19． Watanabe Y, Todani T, Noda T, Yamamoto S: 
Standard splenic volume in children and young adults 
measured from CT images. Surg Today 1997; 27: 726-
728
20． Hayashi H, Beppu T, Okabe H, Nitta H, Imai K, 
Doi K, et al. : Combined measurements of serum 
bile acid level and splenic volume may be usefulto 
noninvasively assess portal venous pressure. J 
Gastroenterol 2012; 47: 1336-1341
21． Dommerby H, Stangerup SE, Stangerup M, Hancke 
S: Hepatosplenomegaly in infectious mononucleosis, 
assessed by ultrasonic scanning. J Laryngol Otol 
1986; 100: 573-579
22． Pozo AL, Godfrey EM, Bowles KM: Splenomegaly: 
investigation, diagnosis and management. Blood Re 
2009; 23: 105-111
23． Petroianu A: Drug-induced splenic enlargement. 
Expert Opin Drug Saf 2007; 6: 199-206
24． Preece SR, Schriber SM, Choudhury KR, Suhocki PV, 
Smith TP, Kim CY: Coil embolization of the splenic 
artery: impact on splenic volume. J Vasc Interv 
Radiol 2014; 25: 859-865
25． Tien YW, Liu KL, Hu RH, Wang HP, Chang KJ, Lee 
PH: Risk of varices bleedingafter spleen-preserving 
distal pancreatectomy with excision of splenic artery 
and vein. Ann Surg Oncol 2010; 17: 2193-2198
26． Yoon YS, Lee KH, Han HS, Cho JY, Ahn KS: Patency 
of splenic vessels after laparoscopic spleen and 
splenic vessel-preserving distal pancreatectomy. Br J 
Surg 2009; 96: 633-640
27． Oida T, Mimatsu K, Kano H, Kawasaki A, Kuboi 
Y, Fukino N, et al. : Post-gastrectomy spleen 
－91－
Tezuka, Kimura, Hirai, Watanabe, Sugawara, Fukumoto, Okazaki, Yano, Hachiya, Suzuki
enlargement and esophageal varices: distal vs 
totalgastrectomy. World J Gastroenterol 2010; 16: 
2801-2805
28． Kiyama T, Mizutani T, Okuda T, Fujita I, Tokunaga 
A, Tajiri T, et al. : Postoperative changes in body 
composition after gastrectomy. J Gastrointest Surg 
2005; 9: 313-319
29． Cho HJ, Ko IH: Splenic lymphoid change in abdominal 
neoplasmic patients--analysis of 121 cases. J Korean 
Med Sci 1994; 9: 230-238
30． Blamey RW, Evans DM: Spleen weight in rats during 
tumour growth and in homograft rejection. Br J 
Cancer 1971; 25: 527-532
31． Edwards A: The response of the reticulo-endothelial 
system to a cancer. Br J Surg 1966; 53: 874-880
32． Sasaki K, Ito T: Effects of estrogen and progesterone 
on the spleen of the mouse: a light and electron 
microscopic study. Arch Histol Jpn 1981; 44: 203-213
33． Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe 
RB: Tissue distribution of estrogen receptors alpha 
（ER-alpha） and beta （ER-beta） mRNA in the 
midgestational human fetus. J Clin Endocrinol Metab 
1997; 82: 3509-3512
